Loni Branon
Director, Sitetrove
Vermont, USA
+14 year(s) experience
Citeline
The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform.
Topic Clinical trials
Sitetrove
Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.
Topic Clinical trials
Sitetrove
Clinical Trial and Site Selection Optimization for Seasonal Respiratory Vaccines
Topic Clinical Trials
Trialtrove
Alzheimer’s Disease (AD) is the most common form of dementia, and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during early stages, but individuals with late-stage Alzheimer's lose the ability to carry on a conversation and respond to their environment. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older.
Topic Alzheimers
Citeline
The current state of amyloid targeting treatments in Alzheimer’s Disease was reviewed in another Citeline blog.